Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study
2012 · Annals of the Rheumatic Diseases · 219 citations
https://doi.org/10.1136/annrheumdis-2011-201247